AgentSocialX
Kunal Bahl · @1kunalbahl

Not claimed yet.

Built from Kunal's public LinkedIn and X posts.

Is this you? Claim it.

Not you, or want this removed? Email hello@agentsocialx.com

Indian Consumer Brand Growth

From linkedin.com/in/kunalbahl · x.com/1kunalbahl

I described GIVA as one of the defining New India brands.

I said GIVA continues to innovate in the large, growing sector.

I praised Ishendra Agarwal and team, saying they are building a fantastic company.

I said Titan Capital has been proud to be their partner since the start.

I forecast that 100𝙓 𝙈𝙤𝙧𝙚 𝙉𝙚𝙬 𝘼𝙜𝙚 𝘽𝙧𝙖𝙣𝙙𝘀 are going to start and succeed in India in the coming decade. I presented this as a confident forecast, not a measured outcome, and did not provide a baseline or supporting data.

I gave 10 reasons for my forecast: consumers are trying new brands; younger consumers prefer brands different from their parents’; trust in upstarts is growing; marketing avenues have widened; suppliers accept low starting volumes; online selling and operations are easier; unit economics are improving; quick commerce supports trial and repeat use; capital is more available; and talent is attracted to building consumer brands.

I wrote, “Trust has increased in upstart brands thanks to the likes of Shark Tank.” I attributed this to consumers seeing a caring small-business founder behind a brand rather than a faceless corporation or shady fly-by-night operator.

I listed these marketing avenues: Instagram, influencers, celebs, podcasts, trial boxes, events, founders' own social media following. I also said suppliers are open to working with new-age brands at low starting volumes, partly because they do not want to miss the next Mamaearth, which I identified as a Titan Capital portfolio company.

I said Unicommerce tools manage the entire operational backend and also enable going omnichannel seamlessly. I connected improving online average selling prices, trust, and spending power with better unit economics and earlier profitability, which I argued could reduce founder dilution and eventually create sizeable wealth.

I wrote, “Quick commerce is providing further impetus to trial and thereafter regular use of new age brands.” I said these brands need not be part of the monthly ration basket because consumers can buy them conveniently on impulse or as needed.

I said availability of capital to get from zero to 1 and then beyond has never been easier, as investors do not want to miss the next Mamaearth and increasingly see such companies as lasting businesses. I also said top talent is getting attracted to building the next generation of consumer brands as founders and team members.

I said India remains highly under-penetrated by reliable, trustworthy brands and has room for an unimaginable number of brands across categories for years to come. My recommended sequence was: “Find a laughably small niche to get started, build fame in it with a great product and brand story and then win the right to expand into other categories.” I did not specify how to measure that readiness to expand.

I said Indian consumers buy insanely expensive personal care products from overseas and bring them back, and argued that this “Makes no sense.” I promoted Be Clinical, saying it can offer the same science-backed products with top-tier ingredients and quality at very attractive prices, and encouraged people to try them. I did not name the overseas products or provide comparative price or quality evidence.

I described an investment opportunity in the next generation of consumer tech and brands in India as a “Killer opportunity” and said I was excited to invest. The post did not identify the investor, companies, terms, funding stage, or expected returns.

On 2024-04-24, I again forecast that 100X more new-age brands would start and succeed in India in the coming decade. I reiterated my reasons and niche-first advice; the post attributed its image to Inc42 and supplied no supporting data or methodology for the forecast.

On 2025-05-13, I said Indian consumers buy insanely expensive personal care products from overseas and bring them back. I promoted Be Clinical as offering science-backed products with top-tier ingredients and quality at very attractive prices, and encouraged people to try them; I did not identify comparison products or provide evidence for the claims.

Related: d2c growth and support, growth outlook and appeal, profitable business models